The Board of Directors has terminated President and Chief Executive Officer, Douglas Bryant and appointed, on an interim basis, Michael Iskra as Chief Executive Officer and Robert Bujarski as Presiden...
Global executive will lead the clinical research strategy and execution for pulse intravascular lithotripsy BOSTON–(BUSINESS WIRE)–AVS (Amplitude Vascular Systems, Inc), an early-stage me...
Additionally, Martin B. Leon, M.D. Appointed as Chair of its Clinical Advisory Board DUBLIN–(BUSINESS WIRE)– CroíValve, an Irish-U.S. based medical device company with a novel, transcathe...
HUNTINGTON BEACH, Calif. & HOUSTON & GOLD COAST, Australia–(BUSINESS WIRE)–BiVACOR, Inc., a clinical-stage medical technology company developing a total artificial heart (TAH), tod...
NEW YORK–(BUSINESS WIRE)–Synchron, the endovascular brain-computer interface (BCI) company developing technology designed to restore functionality in patients with motor impairment, today ...
Value-Building Medical Device Executive with 20-Year Record of Driving Market-Leading Growth Across Orthopedics and Spine Businesses Global Leader with Extensive M&A Integration Expertise and Comm...
A seasoned leader, Sung brings deep finance, capital markets, and strategy experience across the medical device industry November 20, 2023 09:00 AM Eastern Standard Time MOUNTAIN VIEW, Calif.–(B...
November 13, 2023 08:30 AM Eastern Standard Time BRISBANE, Calif.–(BUSINESS WIRE)–Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and derma...
